Annogen

Annogen Announces Research Collaboration with Orchard Therapeutics for the Development of CNS-cell Specific Promoters

Annogen to develop immune cell-specific human promoters for certain Orchard pre-clinical programmes 4 June 2024 -- Amsterdam, The Netherlands -- Annogen, a company with expertise in bespoke promoter design and gene expression engineering, today announced a research collaboration with Orchard Therapeutics, a global gene therapy leader, for the identification of immune cell-specific human promoters for...
Science Park 406, 1098 XH, Amsterdam, The Netherlands

+31 (0) 20 2470020